BSc, Biology, University of Ottawa

Laura’s role include market access assessments and net pricing analyses, and providing strategic expertise on biopharmaceutical market access, market forecasting, and product launch planning service offerings. He role also includes reparation of Patented Medicine Prices Review Board (PMPRB) submissions and assessing compliance with the PMPRB’s guidelines.

Prior to joining PDCI in 2020, Laura worked in Natural Health Products and Cannabis consulting as a Project Manager supporting Health Canada submissions. Laura is currently pursuing her MBA specializing in Innovation Leadership. She looks forward to completing her degree in fall 2022.